These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32316773)

  • 1. How can we improve uptake of oral HIV pre-exposure prophylaxis for transgender individuals?
    Radix AE; Harris AB; Goldstein ZG
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):835-838. PubMed ID: 32316773
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Antiretroviral Treatment and Pre-exposure Prophylaxis in Transgender Individuals.
    Poteat TC; Radix A
    Drugs; 2020 Jul; 80(10):965-972. PubMed ID: 32451925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection.
    Tracer H; Jasmin W
    Am Fam Physician; 2019 Nov; 100(10):637-638. PubMed ID: 31730313
    [No Abstract]   [Full Text] [Related]  

  • 5. Pre-exposure Prophylaxis Use Among Predominantly African American and Hispanic Women at Risk for HIV Acquisition in New York City.
    Theodore DA; Zucker J; Carnevale C; Grant W; Adan M; Borsa A; Richards P; Olender S; Cohall A; Gordon P; Sobieszczyk ME
    J Assoc Nurses AIDS Care; 2020; 31(1):110-114. PubMed ID: 31789687
    [No Abstract]   [Full Text] [Related]  

  • 6. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
    Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
    AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaching High-Risk Patients for HIV Preexposure Prophylaxis.
    Riddell J; Cohn JA
    JAMA; 2016 Jul; 316(2):211-2. PubMed ID: 27404188
    [No Abstract]   [Full Text] [Related]  

  • 8. Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know.
    Katz KA; Park AJ; Marcus JL
    Dermatol Clin; 2020 Apr; 38(2):233-238. PubMed ID: 32115133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Close, But Not Quite: One in Twenty Trans and Gender Diverse Individuals Assigned Female at Birth Are Being Prescribed the Wrong Kind of PrEP.
    Grov C; Patel VV; D'Angelo AB; Zohra F; Appenroth MN
    J Acquir Immune Defic Syndr; 2021 Oct; 88(2):e10-e11. PubMed ID: 34506363
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with PrEP Support and Disclosure Among YMSM and Transgender Individuals Assigned Male at Birth in Chicago.
    Phillips G; Raman A; Felt D; Han Y; Mustanski B
    AIDS Behav; 2019 Oct; 23(10):2749-2760. PubMed ID: 31228025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audit of patient retention in pre-exposure prophylaxis (PrEP) services in an integrated sexual reproductive health service setting.
    Cochrane E; Knapper C
    Int J STD AIDS; 2019 Dec; 30(14):1432-1435. PubMed ID: 31795927
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving HIV pre-exposure prophylaxis for infants.
    Coovadia H; Moodley D
    Lancet; 2016 Feb; 387(10018):513-514. PubMed ID: 26603916
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV Prevention Method Preferences Within Sexual Partnerships Reported by HIV-Negative MSM and TW in Tijuana, Mexico.
    Pines HA; Patrick R; Smith DM; Harvey-Vera A; Blumenthal JS; Rangel G; Semple SJ; Patterson TL
    AIDS Behav; 2020 Mar; 24(3):839-846. PubMed ID: 30945030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is sub-Saharan Africa ready for pre-exposure prophylaxis?
    Bernier A; Gapiya J; Sylla A; Anoma C; Somda M; Dah E; Aranda JF; Himmich H
    Lancet HIV; 2016 Apr; 3(4):e154-5. PubMed ID: 27036989
    [No Abstract]   [Full Text] [Related]  

  • 16. Trial size, HIV pre-exposure prophylaxis, and breastfeeding.
    Bird SM
    Lancet; 2016 May; 387(10033):2090-2091. PubMed ID: 27301821
    [No Abstract]   [Full Text] [Related]  

  • 17. Trial size, HIV pre-exposure prophylaxis, and breastfeeding - Authors' reply.
    Lombard C; Cousens S; Tylleskär T; Van de Perre P; Nagot N
    Lancet; 2016 May; 387(10033):2091. PubMed ID: 27301822
    [No Abstract]   [Full Text] [Related]  

  • 18. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing PrEP uptake and adherence among MSM and TW sex workers in Lima, Perú: what and whom do different patients trust?
    Longino A; Montano MA; Sanchez H; Bayer A; Sanchez J; Tossas-Milligan K; Duerr A; Molina Y
    AIDS Care; 2020 Feb; 32(2):255-260. PubMed ID: 31242753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods and Approaches to HIV Prevention.
    Balthazar MS
    J Assoc Nurses AIDS Care; 2017; 28(1):19-24. PubMed ID: 27751633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.